Each day, the Benzinga Pro news team highlights several stocks with Trading Idea potential. Be the first to see them by becoming a Benzinga Pro user!
Allergan plc AGN stock was trading higher by more than 2 percent early Monday morning after the company reported its first-quarter results. The pharmaceutical company said it earned $3.74 per share in the first quarter on revenue of $3.67 billion versus expectations of $3.35 per share and $3.59 billion.
First Data Corp FDC soared higher by nearly 10 percent in reaction to its first-quarter results. The commerce-enabling technology and solutions company said it earned 29 cents per share in the first quarter on revenue of $2.08 billion versus expectations of 26 cents per share and $1.86 billion.
Sprint Corp S fell nearly 15 percent despite confirming a merger agreement with T-Mobile Us Inc TMUS. The merger in the wireless telecom industry will see the No. 3 and No. 4 players combine into one entity. But the regulatory path ahead remains uncertain and requires the seal of approval from multiple regulatory agencies.
Pluristem Therapeutics Inc. PSTI soared 16 percent. The developer of placenta-based cell therapy products said the FDA cleared its Investigational New Drug (IND) application for its PLX-R18 cell therapy in the treatment of acute radiation syndrome (ARS).
Edge Therapeutics Inc EDGE inched higher by nearly 1 percent before shares were halted. The clinical-stage biotechnology said in a press release it's conducting a "comprehensive review of strategic alternatives focused on maximizing stockholder value."
26 Stocks Moving In Monday's Pre-Market Session
A Peek Into The Markets: US Stock Futures Up Ahead Of Economic Data
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
